Shree Hari Chemicals FY26 Revenue Up 31% to Rs 184.5 Crore

CHEMICALS
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Shree Hari Chemicals FY26 Revenue Up 31% to Rs 184.5 Crore

Shree Hari Chemicals reported a 31% jump in revenue to Rs 184.50 crore for FY 2025-26, though net profit dipped to Rs 4.12 crore. The company announced a Rs 40.24 crore preferential issue of warrants to promoters and approved major related party transactions with Shubhalakshmi Polyesters and Shubhlaxmi Dyetex.

Shree Hari Chemicals FY26 Performance and Fundraising

Revenue: Rs 184.50 crore | Net Profit: Rs 4.12 crore

Reader Takeaway: Revenue grew 31% while profit margins compressed; watch promoter warrant infusion for future capital deployment plans.

What just happened

Shree Hari Chemicals Export Limited released its 39th Annual Report for FY 2025-26. The company reported a significant revenue increase to Rs 184.50 crore, up from Rs 141.20 crore in the previous fiscal. Despite this growth, net profit declined to Rs 4.12 crore from Rs 5.10 crore in FY 2024-25. The board has also greenlit a preferential issue of 22,85,000 convertible warrants to promoters at Rs 176.10 each, totaling Rs 40.24 crore.

Why this matters

The fundraising via warrants indicates promoter confidence and provides the company with capital for expansion and general corporate use. Shareholders have also cleared material related party transactions, each valued at Rs 50 crore, with Shubhalakshmi Polyesters Limited and Shubhlaxmi Dyetex Private Limited for ongoing trade operations.

Board and Management Update

Significant leadership changes were confirmed: Shri Amrut Urkude joins as an Independent Director. Additionally, Shri Bankesh Chandra Agrawal has been re-appointed as Chairman and Managing Director, while Shri Sarthak Agarwal and Shri Nihit Agarwal remain as whole-time directors for the next three years.

Risks to watch

Investors should monitor the impact of increased related party transactions on operational margins and the effective utilization of funds raised from the warrant issue to ensure long-term value creation.

What to track next

Watch for updates on how the Rs 40.24 crore infusion is deployed into subsidiary investments and production capacity expansions within the dyes and intermediates market.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.